What Dialysis Dose Should Be Provided in Acute Renal Failure? A Review

Advances in Renal Replacement Therapy

Volumn 2, Issue 3, 1995, Pages 255-264

  Leblanc, Martine ^a   Tapolyai, Mihály ^a   Paganini, Emil P ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

acute renal failure; continuous renal replacement therapy; Dialysis delivery; hemodialysis; mortality

Indexed keywords

ACUTE KIDNEY FAILURE; ARTIFICIAL MEMBRANE; HUMAN; KIDNEY TRANSPLANTATION; METHODOLOGY; MORTALITY; REVIEW; SURVIVAL; TIME;

HUMAN; KIDNEY FAILURE, ACUTE; MEMBRANES, ARTIFICIAL; RENAL REPLACEMENT THERAPY; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0029338280     PISSN: 10734449     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1073-4449(12)80059-8     Document Type: Article

References (70)

1. Survival as an index of adequacy of dialysis
2. Survival of hemodialysis patients in the United States is improved with a greater quantity of dialysis
3. Effects of dose of dialysis on morbidity and mortality
4. A mechanistic analysis of the National Cooperative Dialysis Study
5. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis
6. A hypothesis: The protein catabolic rate is dependent on the type and amount of treatment in dialyzed uremic patients
7. The correlation between Kt/V and protein catabolic rate-A self-fulfilling prophecy
8. Risk factors and outcome of hospital-acquired renal failure
9. Acute renal failure in the medical intensive care unit: Predisposing, complicating factors and outcome
10. Cause of death in acute renal failure
11. Outcome in acute renal failure
12. Risk factors influencing survival in ICU acute renal failure
13. Uremic and non-uremic complications in acute renal failure: Evaluation of early and frequent dialysis on pronostic
14. The role of intensive dialysis in acute renal failure
15. Delivered dialysis dose may influence acute renal failure outcome in ICU patients
16. Second generation logarithmic estimates of single-pool variable volume Kt/V: An analysis of error
17. Predicting outcome in ICU acute dialysis patients: An accurate scoring system
18. Acute renal failure
19. Plasma volume changes during hemodialysis
20. Fluid balance during hemodialysis and hemodialysis and hemofiltration; the effect of dialysate sodium and a variable ultrafiltration rate
21. Dialysate sodium concentration: Hypertension, and pulmonary edema in hemodialysis patients
22. A randomized double-blind trial of dialysate sodium of 145 mEq/L, 150 mEq/L, and 155 mEq/L
23. Modulated dialysis: A new strategy for the treatment of intradialytic tolerance
24. Changes in plasma volume during hemodialysis with ultrafiltration and sodium modeling
25. Improved left ventricular contractility with cool temperature hemodialysis
26. Extracorporeal treatment of acute renal failure: Methods, indications, quantified and personalized therapeutic approach
27. Continuous renal replacement therapies in the treatment of acute renal failure in intensive care unit patients. Part 1. Theorical aspect and techniques. Part
28. High dialysate flow rate continuous arteriovenous hemodialysis: A new approach for the treatment of acute renal failure and tumor lysis syndrome
29. Acute renal failure associated with multiple organ failure: Pump-assisted continuous venovenous hemonltration, the ultimate treatment modality
30. Continuous renal replacement therapies in severely burned patients
31. Effect of renal replacement therapy on patients with combined acute renal failure and fulminant hepatic failure
32. Continuous venovenous hemofiltration with dialysis removes cytokines from the circulation of septic patients
33. The potential role of hemofiltration in the treatment of patients with septic shock and multiple organ dysfunction syndrome
34. Therapeutic alternatives to renal replacement for critically ill patients in acute renal failure
35. A prospective study of continuous hemodiafiltration in the management of severe acute renal failure in critically ill surgical patients
36. Does hemodialysis delay recovery from acute renal failure?
37. Complement activation retards resolution of acute ischemic renal failure in the rat
38. Effect of the dialysis membrane in the treatment of patients with acute renal failure
39. Differences between KT/V measured during dialysis and KT/V predicted from manufacturer clearance data
40. Biocompatibility of dialysis membranes
41. Activation of complement by hemodialysis membranes: Polyacrylo-nitrile binds more C3a than cuprophan
42. Efficiency and biocompatibility of membranes
43. Composition of polymer membranes for therapies of end-stage renal disease
44. Transmembra-nous transport and absorption of ß2-microglobulin during hemodialysis using polysulfone, polyacryloni-trile, polymethylmethacrylate and cuprammo
45. What are the important considerations in the care of critically ill patients with acute renal failure?
46. Protein cata-bolic rate in patients with acute renal failure on continuous arteriovenous hemofiltration and total parenteral nutrition
47. A comparison of metabolic control by continuous and intermittent therapies in acute renal failure
48. Kt/V in continuous dialysis techniques
49. Solute transport in continuous hemodialysis: A new treatment for acute renal failure
50. Continuous arteriovenous hemodianltration: An aggressive approach to the management of acute renal failure
51. Solute clearances with high dialysate flow rates and glucose absorption from the dialysate in continuous arteriovenous hemodialysis
52. Middle molecule clearance in continuous arteriovenous hemodialysis
53. Kt/V: patients do not get what the physician prescribes
54. Accurate in vivo measurement of dialyzer urea clearance (Ku) and mass transfer coefficient: A daunting task
55. Non-heparin continuous renal replacement is possible
56. Slow continuous hemofiltration and slow continuous ultrafiltration
57. Hemodialysis without anticoagulation
58. Effect of heparin modeling on delivered hemodialysis therapy
59. Blood recirculation in intravenous catheters for hemodialysis
60. Factors affecting delivery of high-efficiency dialysis using temporary vascular access
61. Causes, kinetics and clinical implications of post-hemodialysis urea rebound
62. A regional blood circulation alternative to in-series two-compartment urea kinetic modeling
63. Accuracy of Kt/V estimations in high-flux haemodiafiltration using per cent reduction of urea: Incorporation of urea rebound
64. Post-dialysis urea rebound (PDUR) after "long" session length (3.5-4.5 hour) hemodialysis
65. Post-dialysis urea rebound: Determinants and influence on urea kinetics in hemodialysis
66. Solute rebound in highly efficient dialysis: impact on quantification of therapy
67. Postdialysis urea rebound: Measurement, prediction and effects of regional blood flow
68. Assessing adequacy of hemodialysis: Urea modeling
69. The peak concentration hypothesis: A urea kinetic approach to comparing the adequacy of continuous ambulatory peritoneal dialysis and hemodialysis